SynthesisArchives of pharmacal research2026
Evaluating the clinical effects of GLP-1 receptor agonists for Alzheimer's and Parkinson's diseases using minimal clinically important difference: systematic review and meta-analysis.
Yomna Elghanam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.